Understanding why women join a CMV vaccine study
Part of Infections, Women’s health & pregnancy clinical trials.
This study talks to women about why they chose to join the CMV vaccine trial. Researchers want to learn what helps or hinders participation, so future vaccine studies can be better designed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 18 and 40.
- You are currently enrolled in the CMVCTORY vaccine trial.
- You agree to take part in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a vaccine designed to help the body fight cytomegalovirus (CMV) in children who test positive for CMV and are about to receive a donor stem cell transplant. If it works, it may reduce CMV-related illness during recovery after transplant.
This trial tests a vaccine to prevent cytomegalovirus (CMV) infection in people awaiting a first liver transplant. You may be eligible if you have never been infected with CMV and are scheduled to receive a liver transplant within the next 1 to 12 months.
This study looks at why people with uterine cancer choose to join clinical trials. It aims to make future research easier and better informed.
This trial tests a vaccine designed to boost immunity against CMV (a common virus) and prevent active CMV infection in people receiving a half-matched stem cell transplant. It may help protect you from CMV-related complications after transplant.
This study looks at how the immune system responds to a first-time cytomegalovirus (CMV) infection during pregnancy. The goal is to find better ways to predict if the virus will pass to the baby.
This study tests a mobile health tool (an app) and related surveys to improve knowledge and screening awareness for cervical cancer, including HPV risk and acceptability. It involves people working in cervical cancer screening and women in specific communities, with participation based on consent and eligibility for screening.
Hear when a new Recruitment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.